Proceedings of the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast, April 26–28, 2003, Philadelphia, Pennsylvania

Authors

  • Gordon F. Schwartz M.D., M.B.A.,

    Corresponding author
    1. Department of Surgery, Jefferson Medical College, Philadelphia, Pennsylvania
    • Department of Surgery, Jefferson Medical College, 1015 Chestnut Street, Suite 510, Philadelphia, PA 19107-4305
    Search for more papers by this author
    • Fax: (215) 627-3925

  • Gabriel N. Hortobagyi M.D.,

    1. Department of Breast Medical Oncology, M. D. Anderson Cancer Center, Houston, Texas
    Search for more papers by this author
  • Consensus Conference Committee

    Search for more papers by this author
    • The following were participants in the Consensus Conference on Neoadjuvant Chemotherapy in Carcinoma of the Breast: Co-Chairmen: Dr. Gordon F. Schwartz (Jefferson Medical College, Philadelphia, PA) and Dr. Gabriel N. Hortobagyi (M.D. Anderson Cancer Center, Houston, TX). Surgeons: Dr. Blake Cady (Brown University School of Medicine, Providence, RI), Dr. Krishna B. Clough (Institute Curie, Paris, France), Dr. Domenico M. D'Ugo (Universita Cattolica del Sacro Cuore, Rome, Italy), Dr. Laura J. Esserman (University of California San Francisco, San Francisco, CA), Professor Ian S. Fentiman (Guy's Hospital, London, UK), Dr. Oreste Gentilini (European Institute of Oncology, Milan, Italy), Dr. Armando E. Giuliano (John Wayne Cancer Institute, Santa Monica, CA), Dr. Terry P. Mamounas (Aultman Center Center, Canton, OH), Dr. Peter I. Pressman (Weill Medical College of Cornell University, New York, NY), Dr. Emiel J. Th. Rutgers (Netherlands Cancer Institute, Amsterdam, The Netherlands), Dr. Gordon F. Schwartz (Jefferson Medical College, Philadelphia, PA), Dr. Daniela Terribile (Universita Cattolica del Sacro Cuore, Rome, Italy), Dr. Theodore N. Tsangaris (The Johns Hopkins Hospital, Baltimore MD), Dr. Michael Untch (University of Munich Klinikum Grosshadern, Munich, Germany), and Professor Cornelis J. H. van de Velde (Leiden University Medical Center, Leiden, The Netherlands). Medical Oncologists: Dr. Aman U. Buzdar (M. D. Anderson Cancer Center, Houston, TX), Dr. Daniel F. Hayes (University of Michigan Medical School, Ann Arbor, MI), Dr. Gabriel N. Hortobagyi (M. D. Anderson Cancer Center, Houston, TX), Dr. Clifford Hudis (Memorial Sloan-Kettering Cancer Center, New York, NY), Dr. Olivier Rixe (Salpetriere Hospital, Paris, France), Professor Ian Edward Smith (The Royal Marsden NHS Trust, London, UK), and Dr. Sandra M. Swain (Cancer Therapeutics Branch, National Cancer Institute, Bethesda, MD). Radiation Oncologists: Dr. Thomas A. Buchholz (M. D. Anderson Cancer Center, Houston, TX), Dr. Lydia T. Komarnicky (Drexel University College of Medicine, Philadelphia, PA), Dr. Robert R. Kuske, Jr. (Arizona Oncology Services, Scottsdale, AZ), Dr. Beryl McCormick (Memorial Sloan-Kettering Cancer Center, New York, NY), and Dr. Lawrence J. Solin (University of Pennsylvania School of Medicine, Philadelphia, PA). Pathologists: Dr. Fred Gorstein (Jefferson Medical College, Philadelphia, PA), Dr. Roland Holland (University Hospital Nijmegen, Nijmegen, The Netherlands), Dr. Shahla Masood (University of Florida Health Science Center, Jacksonville, FL), Dr. David L. Page (Vanderbilt University Medical Center, Nashville, TN), and Dr. Juan P. Palazzo (Jefferson Medical College, Philadelphia, PA). Breast Imagers (Radiologists): Dr. R. James Brenner (John Wayne Cancer Institute, Santa Monica, CA), Dr. Stephen A. Feig (Mt. Sinai Medical Center, New York, NY), and Dr. Daniel B. Kopans (Massachusetts General Hospital, Boston, MA).


Abstract

A consensus conference regarding the role of neoadjuvant chemotherapy in patients with carcinoma of the breast was held in April 2003 in Philadelphia to review the evidence in support of this form of treatment, discuss the issues related to its routine application, and establish more formal guidelines for its use in patients with all stages of breast carcinoma.

Ancillary